InsidersTradesSigma
Explore the full record of transactions filed by Hoang Peter L., 首席执行官. Director active across 1 company, notably Marker Therapeutics, Inc.. Cumulatively, 1 filings have been logged. Activity tracked since 24 March 2022. The latest transaction was disclosed on 24 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Peter L. Hoang is President and CEO of Marker Therapeutics, Inc. He leads the company and is responsible for its strategy and operations. His leadership is crucial for the company's development and innovation.